These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17990842)

  • 21. Population genetics of anthelmintic resistance in parasitic nematodes.
    Gilleard JS; Beech RN
    Parasitology; 2007; 134(Pt 8):1133-47. PubMed ID: 17608973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model.
    Depondt C
    Acta Neurol Belg; 2006 Dec; 106(4):157-67. PubMed ID: 17323833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics in heart failure: promises and challenges.
    de Boer RA; van der Harst P; van Veldhuisen DJ; van den Berg MP
    Expert Opin Pharmacother; 2009 Aug; 10(11):1713-25. PubMed ID: 19558337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacogenomics: way to individual therapy].
    Piruzian AL
    Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemiological night where all patients are black: will pharmacogenetics shed some light?
    de Gaetano G; Cerletti C; Iacoviello L; Donati MB
    Thromb Res; 2003; 112(5-6):273-4. PubMed ID: 15041269
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolving science of pharmacogenetics: clinical and ethnic perspectives.
    Lin KM; Poland RE; Wan YJ; Smith MW; Lesser IM
    Psychopharmacol Bull; 1996; 32(2):205-17. PubMed ID: 8783890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-coupled receptor pharmacogenetics.
    Thompson MD; Siminovitch KA; Cole DE
    Methods Mol Biol; 2008; 448():139-85. PubMed ID: 18370234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical application of pharmacogenetics in gastrointestinal diseases.
    Saito YA; Camilleri M
    Expert Opin Pharmacother; 2006 Oct; 7(14):1857-69. PubMed ID: 17020413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetic studies of epilepsy drugs: are we there yet?
    Spurr NK
    Trends Genet; 2006 May; 22(5):250-2. PubMed ID: 16564110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine.
    Rosskopf D; Michel MC
    Pharmacol Rev; 2008 Dec; 60(4):513-35. PubMed ID: 19074621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenetics in cardiovascular diseases therapy--treatment according guidelines or according the individual requirement?].
    Bultas J
    Cas Lek Cesk; 2010; 149(10):476-81. PubMed ID: 21121138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA; Arnhold IJ
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of drug resistance.
    Sisodiya SM
    Epilepsia; 2005; 46 Suppl 10():33-8. PubMed ID: 16359469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
    Anderson GD
    Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and pharmacogenetics of chemotherapeutic agents.
    Dawood S; Leyland-Jones B
    Cancer Invest; 2009 Jun; 27(5):482-8. PubMed ID: 19479485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.